Free Shipping for all Order of $99
Showing all 10 results
-
CagriSema 10MG/10MG
Original price was: $185.00.$178.00Current price is: $178.00.CagriSema is a combo of two powerful GLPs
-
GLP-1SG 10MG
Original price was: $93.00.$83.00Current price is: $83.00.GLP-1S is a synthetic peptide, is designed to activate GLP-1 receptors, supporting the study of metabolic pathways for research purposes.
-
GLP-2TZ 10MG
Original price was: $93.00.$83.00Current price is: $83.00.GLP-2TZ is a glucagon-like peptide-1 (GLP-1) and glucagon receptor dual agonist designed to offer a comprehensive approach to metabolic health.
-
GLP-2TZ 15MG
Original price was: $125.00.$95.00Current price is: $95.00.Newest Product!! GLP-2T 15MG is a synthetic glucagon-like peptide-1 (GLP-1) and glucagon receptor dual agonist. This is a new product we are
-
GLP-2TZ 20MG
$150.00Newest Product!! GLP-2T 15MG is a synthetic glucagon-like peptide-1 (GLP-1) and glucagon receptor dual agonist. This is a new product we are
-
GLP-2TZ 30MG
Original price was: $210.00.$200.00Current price is: $200.00.GLP-2T is a glucagon-like peptide-1 (GLP-1) and glucagon receptor dual agonist.
-
GLP-2TZ 60MG
$325.00GLP-2T is a glucagon-like peptide-1 (GLP-1) and glucagon receptor dual agonist.
-
GLP-3RT 12MG
$120.00GLP-3R 12MG is a GGG tri-agonist that targets GLP-1 and GIP receptors, akin to standard GLP-1 agonists, but also uniquely activates the glucagon receptor.
Clinical Data:
GLP-3RT: Triple–Hormone-Receptor Agonist for Obesity — A Phase 2 Trial
GLP-3RT: A Study (LY3437943) in Participants With Obesity and Cardiovascular Disease (TRIUMPH-3)
GLP-3RT: Triple-Hormone-Receptor Agonist Study for Obesity – A Phase 2 Trial
-
GLP-3RT 24MG
$240.00GLP-3RT 24MG is replacing our GLP-3RT 20MG. GLP-3RT is a GGG tri-agonist that targets GLP-1 and GIP receptors, akin to standard GLP-1 agonists, but also uniquely activates the glucagon receptor.
-
GLP-3RT 6MG
Original price was: $75.00.$65.00Current price is: $65.00.GLP-3R 6MG SPECIAL INTRO PRICE OF $65
GLP-3RT is a GGG tri-agonist that targets GLP-1 and GIP receptors, akin to standard GLP-1 agonists, but also uniquely activates the glucagon receptor.
Clinical Data:
GLP-3RT: Triple–Hormone-Receptor Agonist for Obesity — A Phase 2 Trial
GLP-3RT: A Study (LY3437943) in Participants With Obesity and Cardiovascular Disease (TRIUMPH-3)
GLP-3RT: Triple-Hormone-Receptor Agonist Study for Obesity – A Phase 2 Trial
